Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches

Standing amidst the COVID-19 pandemic, we have faced major medical and economic crisis in recent times which remains to be an unresolved issue till date. Although the scientific community has made significant progress towards diagnosis and understanding the disease; however, effective therapeutics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Amrita, Verma, Ayushi, Bihani, Surbhi, Burli, Ananya, Mantri, Krishi, Srivastava, Sanjeeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222565/
https://www.ncbi.nlm.nih.gov/pubmed/34906319
http://dx.doi.org/10.1016/j.ddtec.2021.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222565/
https://www.ncbi.nlm.nih.gov/pubmed/34906319
http://dx.doi.org/10.1016/j.ddtec.2021.06.004

Ejemplares similares